COVID-19 Incidence Rises This Autumn, Driven by New Variant and Waning Immunity
Table of Contents
The incidence of COVID-19 is increasing across the population, with many individuals either recently confirmed to have contracted the virus or experiencing and recovering from symptoms without formal testing. According to the latest report from the Carlos III Health Institute (ISCIII), as of October 5th, the incidence rate reached 63.8 cases per 100,000 inhabitants – a slight decrease from the peak of 99.3 cases per 100,000 observed during the summer and september months. Experts at the Ministry of Health suggest the situation is approaching “almost endemic” levels, fueled by a combination of factors.
Why is COVID-19 incidence rising?
The rise is due to a combination of factors: the emergence of the Nimbus variant (NB.1.8.1),waning population immunity from previous infections and vaccinations,and increased exposure through activities like returning to work and school after holidays. Small alterations in the virus have also contributed, leading to more pronounced symptoms like fatigue and muscle pain.
Symptoms of the Nimbus Variant (NB.1.8.1)
The current rise in cases is largely attributed to the Nimbus variant (NB.1.8.1), presenting a range of symptoms including:
- Fever
- Headache
- General malaise
- Increased sore throat
- Hoarseness
- Muscle pain
- Respiratory problems
- Extreme tiredness
- Prolonged aches and pains
Notably, sore throat and fatigue are emerging as the most characteristic symptoms of this new variant.
Who is most affected?
The article doesn’t specify particular demographics most affected. However, it implies that individuals with diminished prior immunity are more susceptible.This includes those whose last infection or vaccination was some time ago. Increased exposure in communal settings also affects anyone interacting in those spaces.
Loss of Immunity and Increased Exposure
Rafael Toledo, a Professor of Parasitology and Immunologist at the University of Valencia, explained that “small alterations” in the virus have caught many off guard, resulting in more pronounced consequences than previous variants, notably in terms of fatigue and muscle pain.He further noted that the absence of a important COVID-19 peak meant that prior population immunity had diminished, making individuals more susceptible to infection since september. The return to work and school following the holidays created an ideal environment for transmission.
Increased interaction in enclosed spaces, such as public transport and offices, considerably elevates exposure risk to all viruses. Currently, the influenza virus has not seen a substantial increase in incidence, remaining at a relatively low rate of 20.3 cases per 100,000 inhabitants, according to the latest Health report.
What are the current hospitalization rates?
Hospitalization rates remain relatively stable, at 1.5 cases per 100,000 inhabitants. Of those hospitalized, 29.4% have pneumonia, 7.7% require ICU admission, and 9.1% experience fatality. Since late October 2024, pneumonia cases among hospitalized individuals are at 23.6%, ICU admissions at 4%, and fatality rates are not explicitly stated beyond the overall 9.1%.
